250 related articles for article (PubMed ID: 7245091)
1. Investigation on cyclophosphamide treatment during the preimplantation period. II. In vitro studies on the effects of cyclophosphamide and its metabolites 4-OH-cyclophosphamide, phosphoramide mustard, and acrolein on blastulation of four-cell and eight-cell mouse embryos and on their subsequent development during implantation.
Spielmann H; Jacob-Müller U
Teratology; 1981 Feb; 23(1):7-13. PubMed ID: 7245091
[TBL] [Abstract][Full Text] [Related]
2. In vitro methods for the study of the effects of teratogens on preimplantation embryos.
Spielmann H; Eibs HG; Jacob-Müller U
Acta Morphol Acad Sci Hung; 1980; 28(1-2):105-15. PubMed ID: 7446214
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein.
Hales BF
Cancer Res; 1982 Aug; 42(8):3016-21. PubMed ID: 7046914
[No Abstract] [Full Text] [Related]
4. Enhancement of in vivo and in vitro murine immune responses by the cyclophosphamide metabolite acrolein.
Kawabata TT; White KL
Cancer Res; 1988 Jan; 48(1):41-5. PubMed ID: 3257162
[TBL] [Abstract][Full Text] [Related]
5. Investigations on cyclophosphamide treatment during the preimplantation period. I. Differential sensitivity to maternal cyclophosphamide treatment.
Spielmann H; Jacob-Müller U; Eibs HG; Beckord W
Teratology; 1981 Feb; 23(1):1-5. PubMed ID: 7245082
[TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
Chang TK; Waxman DJ
Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
[TBL] [Abstract][Full Text] [Related]
7. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
Hales BF
Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
[TBL] [Abstract][Full Text] [Related]
8. Relationship of DNA damage and embryotoxicity induced by 4-hydroperoxydechlorocyclophosphamide in postimplantation rat embryos.
Little SA; Mirkes PE
Teratology; 1990 Feb; 41(2):223-31. PubMed ID: 2321166
[TBL] [Abstract][Full Text] [Related]
9. Role of acrolein in cyclophosphamide teratogenicity in rat embryos in vitro.
Mirkes PE; Greenaway JC; Rogers JG; Brundrett RB
Toxicol Appl Pharmacol; 1984 Feb; 72(2):281-91. PubMed ID: 6546458
[TBL] [Abstract][Full Text] [Related]
10. Effect of acrolein on phosphoramide mustard-induced sister chromatid exchanges in cultured human lymphocytes.
Wilmer JL; Erexson GL; Kligerman AD
Cancer Res; 1990 Aug; 50(15):4635-8. PubMed ID: 2369740
[TBL] [Abstract][Full Text] [Related]
11. Blood levels of alkylating metabolites of cyclophosphamide in the mouse after iv or oral administration.
Struck RF; Alberts DS
Cancer Treat Rep; 1984 May; 68(5):765-70. PubMed ID: 6722832
[TBL] [Abstract][Full Text] [Related]
12. Teratogenic effects of cyproterone acetate and medroxyprogesterone treatment during the pre- and postimplantation period of mouse embryos. II. Cyproterone acetate and medroxyprogesterone acetate treatment before implantation in vivo and in vitro.
Eibs HG; Spielmann H; Jacob-Müller U; Klose J
Teratology; 1982 Jun; 25(3):291-9. PubMed ID: 6214037
[TBL] [Abstract][Full Text] [Related]
13. Characterizing the ovotoxicity of cyclophosphamide metabolites on cultured mouse ovaries.
Desmeules P; Devine PJ
Toxicol Sci; 2006 Apr; 90(2):500-9. PubMed ID: 16381661
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of cytogenetic damage by 2-mercaptoethanesulfonate in cultured human lymphocytes exposed to cyclophosphamide and its reactive metabolites.
Wilmer JL; Erexson GL; Kligerman AD
Cancer Res; 1986 Jan; 46(1):203-10. PubMed ID: 3079586
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
Crook TR; Souhami RL; McLean AE
Cancer Res; 1986 Oct; 46(10):5029-34. PubMed ID: 3463409
[TBL] [Abstract][Full Text] [Related]
16. Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide.
Plowchalk DR; Mattison DR
Toxicol Appl Pharmacol; 1991 Mar; 107(3):472-81. PubMed ID: 2000634
[TBL] [Abstract][Full Text] [Related]
17. Possible role of acrolein in 4-hydroperoxycyclophosphamide-induced cell damage in vitro.
Blomgren H; Hallström M
Methods Find Exp Clin Pharmacol; 1991; 13(1):11-4. PubMed ID: 1908032
[TBL] [Abstract][Full Text] [Related]
18. Effects of 4-hydroperoxycyclophosphamide (4-OOH-CP) and 4-hydroperoxydechlorocyclophosphamide (4-OOH-deCICP) on the cell cycle of post implantation rat embryos.
Little SA; Mirkes PE
Teratology; 1992 Feb; 45(2):163-73. PubMed ID: 1615426
[TBL] [Abstract][Full Text] [Related]
19. Recent progress in teratology. A survey of methods for the study of drug actions during the preimplantation period.
Spielmann H; Eibs HG
Arzneimittelforschung; 1978; 28(10):1733-42. PubMed ID: 582678
[TBL] [Abstract][Full Text] [Related]
20. Teratogenicity of cyclophosphamide metabolites: phosphoramide mustard, acrolein, and 4-ketocyclophosphamide in rat embryos cultured in vitro.
Mirkes PE; Fantel AG; Greenaway JC; Shepard TH
Toxicol Appl Pharmacol; 1981 Apr; 58(2):322-30. PubMed ID: 7245204
[No Abstract] [Full Text] [Related]
[Next] [New Search]
